GSK's RSV vaccine meets main goal
GSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines
GSK plc GSK announced positive topline results from a phase III study evaluating the co-administration of its two marketed vaccines — RSV vaccine Arexvy and shingles vaccine Shingrix — in older adults (aged 50 years and older).
GSK's RSV vaccine meets main goal when co-administered with shingles shot
British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles shot, met the main goal of a late-stage trial in adults over 50 years of age.
GSK pursues co-administration of RSV and shingles vaccines
GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new hope.
GSK touts co-administration data for RSV, shingles vaccines as narrowed CDC guidance threatens sales
In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses compared with separate administration of the vaccines.
GSK Reports Positive Data From Co-administration Of RSV And Shingles Vaccines
GSK plc (GSK, GSK.L) announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the
GSK's RSV, Shingles vaccines show on-par immune response in joint trial
(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot together generated the same immune response in a late-stage trial as separate adminstration of the vaccines.
GSK Sees Positive Results in Trial of Combination RSV, Shingles Vaccine
GSK recorded positive topline data in a late stage trial of its respiratory syncytial virus vaccine combined with a shingles vaccine in treating adults 50 years and older. The British pharma giant said Wednesday a Phase 3 study evaluating RSV vaccine Arexvy co-administered with Shingrix met the primary endpoint,
GSK posts late-stage trial win for co-administered RSV and shingles vaccines
GSK (NYSE:GSK) announced Wednesday that its Arexvy vaccine for respiratory syncytial virus (RSV) and its Shingrix vaccine for shingles reached the main goal in a Phase 3 trial when they were co-administered in adults aged 50 and older.
What’s the RSV Vaccine? Here’s What You Need to Know About the UK Rollout
Starting in September, the UK’s new RSV vaccine program will offer protection across all age groups — find out what this ...
The American Journal of Managed Care2d
New RSV Vaccine Is Likely Cost-Effective for Older Adults, Study Finds
Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...
WGAL7d
Pulmonologist talks about RSV: Symptoms, who's most at risk, effectiveness of vaccine
A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...
Health Beat: The truth About RSV
Often dismissed as just another common cold, RSV can be deadly, especially for infants and older people. Hannah and her twin ...
COVID-19, flu and RSV shots: Do I really need all three?
All flu vaccines for the 2024-25 season will be trivalent, meaning they protect against three different strains of influenza: ...
KOAT Albuquerque on MSN8d
New guidelines for who should take RSV vaccine
It's been more than a year since the Food and Drug Administration approved the first vaccine to treat RSV. Since then, newly ...
'Vaccine fatigue' blamed as roughly half of people in US will skip COVID and flu shots this year
A growing number of U.S. adults are hesitant to get recommended vaccines this fall, a new survey found. Doctors discuss ...
RSV vaccine rolled out in Jersey to combat respiratory illnesses
The Respiratory Syncytial Virus (RSV) vaccine will be rolled out to some older islanders as well as pregnant women. | ITV ...
Free RSV vaccines for pregnant women could be coming next year — here's what you need to know
RSV is a highly infectious virus that is the most common cause of respiratory infections in children. A free vaccine could ...